Europe Clinical Negligence Market By Treatment Provider (Private Practitioners & Healthcare Facilities, National Health Service (NHS) Practitioners & Healthcare Facilities); By Medical Negligence Type (Misdiagnosis and Negligence, Delayed Diagnosis, Incorrect Treatment, Surgical Mistakes, Others); By Application (Pregnancy and Birth Injury Claims, Cancer Diagnosis Claims, Cardiology Claims, Dental Claims, Orthopedic Claim, ENT Claims, Medication Errors & Pharmacy Claims, Pediatric Injury Claim, Personal Injury Claim, Cerebral Palsy Claim, Others); By Country (France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Europe clinical negligence market is growing at an estimated CAGR of 13.4% over the forecast period. While it is totally human to make error, there are certain errors or mistakes that prove fatal not just for them but for everyone else. One such mistake is of clinical negligence, which definitely is serious. Medical or clinical negligence primarily happens to be an act or an error of omission by a medical expert or practitioner that deviates from normal standards and results in causing injury to the patient. The cares of clinical negligence are on a rise across the globe, but the number falls on a higher side, specifically in the continent of Europe. Despite having the greatest number of developed nations that provide best medical treatments, the cases of clinical negligence are surging. This is the reason why the Europe clinical negligence market is taking giant strides on the path of progress.
The recent COVID-19 pandemic was a huge setback to this planet. After China, countries like Italy, Spain and France were among first few nations to see spread of infections. The number of hospitalizations were high and this is why the health infrastructure in several countries collapsed. And this caused spike in the number of clinical negligence. Several reports including the one by the NHS confirmed this rise.
Treatment Provider
On the basis of treatment provider, the Europe clinical negligence market has been segmented into private practitioners & healthcare facilities, and the National Health Service (NHS) practitioners & healthcare facilities. The National Health Service (NHS) practitioners & healthcare facilities segment accounts for majority of revenue generated by this market. Unlike private hospitals, the number of people seeking treatments in government hospitals are more, and the doctors or medical experts treating them are scare. This is the major reason why cases of clinical negligence are high.
Europe Clinical Negligence Market Revenue & Forecast, (US$ Million), 2022 – 2030
Medical Negligence Type
The medical negligence type segment of the Europe clinical negligence market has been categorised into misdiagnosis and negligence, delayed diagnosis, incorrect treatment, surgical mistakes and others. In majority of cases, the diagnosis is delayed which results in serious complications. Also cases of misdiagnosis and negligence are rising which brings in incorrect treatment.
Application
The application segment of the Europe clinical negligence market has been bifurcated into pregnancy and birth injury claims, cancer diagnosis claims, cardiology claims, dental claims, orthopaedic claim, ENT claims, medication errors & pharmacy claims, pediatric injury claim, personal injury claim, cerebral palsy claim and others. Diagnosis of chronic diseases like cancer and cardiac arrest is usually difficult and hence claims of clinical negligence related to such diseases are on higher side.
Competitive Landscape
The report provides both, qualitative and quantitative research of Europe clinical negligence market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the Europe clinical negligence market are listed below:
- Anthony Gold Solicitors LLP
- Bolt Burdon Kemp
- Clarke Willmott LLP
- Clyde & Co LLP
- Fieldfisher
- Fletchers Solicitors
- Forbes Solicitors LLP
- Hodge Jones & Allen Solicitors Limited
- Irwin Mitchell LLP
- Kingsley Napley LLP
- Leigh Day
- Lime Solicitors
- Longden Walker & Renney Solicitors
- Stewards Law LLP
- Thompson Solicitors LLP
- Other Market Participants
Europe Clinical Negligence Market
By Treatment Provider
- Private Practitioners & Healthcare Facilities
- National Health Service (NHS) Practitioners & Healthcare Facilities
By Medical Negligence Type
- Misdiagnosis and Negligence
- Delayed Diagnosis
- Incorrect Treatment
- Surgical Mistakes
- Others
By Application
- Pregnancy and Birth Injury Claims
- Cancer Diagnosis Claims
- Cardiology Claims
- Dental Claims
- Orthopedic Claim
- ENT Claims
- Medication Errors & Pharmacy Claims
- Pediatric Injury Claim
- Personal Injury Claim
- Cerebral Paisy Claim
- Others
By Country
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015
- 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022
– 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research
Questionnaire
3.1.2. Global Percentage
Breakdown
3.1.3. Primary Interviews:
Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size
Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation
Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s
Perspective**
5. Holistic Overview of Clinical Negligence
Market
6. Market Synopsis:Â Clinical Negligence Market
7. Clinical Negligence Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Clinical
Negligence Market
7.4. Market Determinants
Radar Chart
7.5. Macro-Economic and
Micro-Economic Indicators: Clinical Negligence Market
7.6. Porter’s Five Force
Analysis
7.7. Impact of COVID-19
on Clinical Negligence Market
8.
Europe Clinical Negligence
Market Analysis and Forecasts, 2022 - 2030
8.1.
Overview
8.1.1.
Europe Clinical Negligence Market
Revenue (US$ Mn)
8.2.
Europe Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Treatment Provider
8.2.1.
Private Practitioners and Healthcare
Facilities
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and Penetration, 2015
- 2021
8.2.1.3.
Market Forecast, 2022 - 2030
8.2.1.4.
Compound Annual Growth Rate (CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
France
8.2.1.5.1.1.
Market Estimation, 2015 - 2021
8.2.1.5.1.2.
Market Forecast, 2022 - 2030
8.2.1.5.2.
The UK
8.2.1.5.2.1.
Market Estimation, 2015 - 2021
8.2.1.5.2.2.
Market Forecast, 2022 - 2030
8.2.1.5.3.
Spain
8.2.1.5.3.1.
Market Estimation, 2015 - 2021
8.2.1.5.3.2.
Market Forecast, 2022 - 2030
8.2.1.5.4.
Germany
8.2.1.5.4.1.
Market Estimation, 2015 - 2021
8.2.1.5.4.2.
Market Forecast, 2022 - 2030
8.2.1.5.5.
Italy
8.2.1.5.5.1.
Market Estimation, 2015 - 2021
8.2.1.5.5.2.
Market Forecast, 2022 - 2030
8.2.1.5.6.
Nordic Countries
8.2.1.5.6.1.
Market Estimation, 2015 - 2021
8.2.1.5.6.2.
Market Forecast, 2022 - 2030
8.2.1.5.7.
Benelux Union
8.2.1.5.7.1.
Market Estimation, 2015 - 2021
8.2.1.5.7.2.
Market Forecast, 2022 - 2030
8.2.1.5.8.
Rest of Europe
8.2.1.5.8.1.
Market Estimation, 2015 - 2021
8.2.1.5.8.2.
Market Forecast, 2022 - 2030
8.2.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and Penetration, 2015
- 2021
8.2.2.3.
Market Forecast, 2022 - 2030
8.2.2.4.
Compound Annual Growth Rate (CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
France
8.2.2.5.1.1.
Market Estimation, 2015 - 2021
8.2.2.5.1.2.
Market Forecast, 2022 - 2030
8.2.2.5.2.
The UK
8.2.2.5.2.1.
Market Estimation, 2015 - 2021
8.2.2.5.2.2.
Market Forecast, 2022 - 2030
8.2.2.5.3.
Spain
8.2.2.5.3.1.
Market Estimation, 2015 - 2021
8.2.2.5.3.2.
Market Forecast, 2022 - 2030
8.2.2.5.4.
Germany
8.2.2.5.4.1.
Market Estimation, 2015 - 2021
8.2.2.5.4.2.
Market Forecast, 2022 - 2030
8.2.2.5.5.
Italy
8.2.2.5.5.1.
Market Estimation, 2015 - 2021
8.2.2.5.5.2.
Market Forecast, 2022 - 2030
8.2.2.5.6.
Nordic Countries
8.2.2.5.6.1.
Market Estimation, 2015 - 2021
8.2.2.5.6.2.
Market Forecast, 2022 - 2030
8.2.2.5.7.
Benelux Union
8.2.2.5.7.1.
Market Estimation, 2015 - 2021
8.2.2.5.7.2.
Market Forecast, 2022 - 2030
8.2.2.5.8.
Rest of Europe
8.2.2.5.8.1.
Market Estimation, 2015 - 2021
8.2.2.5.8.2.
Market Forecast, 2022 - 2030
8.3.
Key Segment for Channeling Investments
8.3.1.
By Treatment Provider
9.
Europe Clinical Negligence
Market Analysis and Forecasts, 2022 - 2030
9.1.
Overview
9.2.
Europe Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
9.2.1.
Misdiagnosis and Negligence
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and Penetration, 2015
- 2021
9.2.1.3.
Market Forecast, 2022 - 2030
9.2.1.4.
Compound Annual Growth Rate (CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
France
9.2.1.5.1.1.
Market Estimation, 2015 - 2021
9.2.1.5.1.2.
Market Forecast, 2022 - 2030
9.2.1.5.2.
The UK
9.2.1.5.2.1.
Market Estimation, 2015 - 2021
9.2.1.5.2.2.
Market Forecast, 2022 - 2030
9.2.1.5.3.
Spain
9.2.1.5.3.1.
Market Estimation, 2015 - 2021
9.2.1.5.3.2.
Market Forecast, 2022 - 2030
9.2.1.5.4.
Germany
9.2.1.5.4.1.
Market Estimation, 2015 - 2021
9.2.1.5.4.2.
Market Forecast, 2022 - 2030
9.2.1.5.5.
Italy
9.2.1.5.5.1.
Market Estimation, 2015 - 2021
9.2.1.5.5.2.
Market Forecast, 2022 - 2030
9.2.1.5.6.
Nordic Countries
9.2.1.5.6.1.
Market Estimation, 2015 - 2021
9.2.1.5.6.2.
Market Forecast, 2022 - 2030
9.2.1.5.7.
Benelux Union
9.2.1.5.7.1.
Market Estimation, 2015 - 2021
9.2.1.5.7.2.
Market Forecast, 2022 - 2030
9.2.1.5.8.
Rest of Europe
9.2.1.5.8.1.
Market Estimation, 2015 - 2021
9.2.1.5.8.2.
Market Forecast, 2022 - 2030
9.2.2.
Delayed Diagnosis
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and Penetration, 2015
- 2021
9.2.2.3.
Market Forecast, 2022 - 2030
9.2.2.4.
Compound Annual Growth Rate (CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
France
9.2.2.5.1.1.
Market Estimation, 2015 - 2021
9.2.2.5.1.2.
Market Forecast, 2022 - 2030
9.2.2.5.2.
The UK
9.2.2.5.2.1.
Market Estimation, 2015 - 2021
9.2.2.5.2.2.
Market Forecast, 2022 - 2030
9.2.2.5.3.
Spain
9.2.2.5.3.1.
Market Estimation, 2015 - 2021
9.2.2.5.3.2.
Market Forecast, 2022 - 2030
9.2.2.5.4.
Germany
9.2.2.5.4.1.
Market Estimation, 2015 - 2021
9.2.2.5.4.2.
Market Forecast, 2022 - 2030
9.2.2.5.5.
Italy
9.2.2.5.5.1.
Market Estimation, 2015 - 2021
9.2.2.5.5.2.
Market Forecast, 2022 - 2030
9.2.2.5.6.
Nordic Countries
9.2.2.5.6.1.
Market Estimation, 2015 - 2021
9.2.2.5.6.2.
Market Forecast, 2022 - 2030
9.2.2.5.7.
Benelux Union
9.2.2.5.7.1.
Market Estimation, 2015 - 2021
9.2.2.5.7.2.
Market Forecast, 2022 - 2030
9.2.2.5.8.
Rest of Europe
9.2.2.5.8.1.
Market Estimation, 2015 - 2021
9.2.2.5.8.2.
Market Forecast, 2022 - 2030
9.2.3.
Incorrect Treatment
9.2.3.1.
Definition
9.2.3.2.
Market Estimation and Penetration, 2015
- 2021
9.2.3.3.
Market Forecast, 2022 - 2030
9.2.3.4.
Compound Annual Growth Rate (CAGR)
9.2.3.5.
Regional Bifurcation
9.2.3.5.1.
France
9.2.3.5.1.1.
Market Estimation, 2015 - 2021
9.2.3.5.1.2.
Market Forecast, 2022 - 2030
9.2.3.5.2.
The UK
9.2.3.5.2.1.
Market Estimation, 2015 - 2021
9.2.3.5.2.2.
Market Forecast, 2022 - 2030
9.2.3.5.3.
Spain
9.2.3.5.3.1.
Market Estimation, 2015 - 2021
9.2.3.5.3.2.
Market Forecast, 2022 - 2030
9.2.3.5.4.
Germany
9.2.3.5.4.1.
Market Estimation, 2015 - 2021
9.2.3.5.4.2.
Market Forecast, 2022 - 2030
9.2.3.5.5.
Italy
9.2.3.5.5.1.
Market Estimation, 2015 - 2021
9.2.3.5.5.2.
Market Forecast, 2022 - 2030
9.2.3.5.6.
Nordic Countries
9.2.3.5.6.1.
Market Estimation, 2015 - 2021
9.2.3.5.6.2.
Market Forecast, 2022 - 2030
9.2.3.5.7.
Benelux Union
9.2.3.5.7.1.
Market Estimation, 2015 - 2021
9.2.3.5.7.2.
Market Forecast, 2022 - 2030
9.2.3.5.8.
Rest of Europe
9.2.3.5.8.1.
Market Estimation, 2015 - 2021
9.2.3.5.8.2.
Market Forecast, 2022 - 2030
9.2.4.
Surgical Mistakes
9.2.4.1.
Definition
9.2.4.2.
Market Estimation and Penetration, 2015
- 2021
9.2.4.3.
Market Forecast, 2022 - 2030
9.2.4.4.
Compound Annual Growth Rate (CAGR)
9.2.4.5.
Regional Bifurcation
9.2.4.5.1.
France
9.2.4.5.1.1.
Market Estimation, 2015 - 2021
9.2.4.5.1.2.
Market Forecast, 2022 - 2030
9.2.4.5.2.
The UK
9.2.4.5.2.1.
Market Estimation, 2015 - 2021
9.2.4.5.2.2.
Market Forecast, 2022 - 2030
9.2.4.5.3.
Spain
9.2.4.5.3.1.
Market Estimation, 2015 - 2021
9.2.4.5.3.2.
Market Forecast, 2022 - 2030
9.2.4.5.4.
Germany
9.2.4.5.4.1.
Market Estimation, 2015 - 2021
9.2.4.5.4.2.
Market Forecast, 2022 - 2030
9.2.4.5.5.
Italy
9.2.4.5.5.1.
Market Estimation, 2015 - 2021
9.2.4.5.5.2.
Market Forecast, 2022 - 2030
9.2.4.5.6.
Nordic Countries
9.2.4.5.6.1.
Market Estimation, 2015 - 2021
9.2.4.5.6.2.
Market Forecast, 2022 - 2030
9.2.4.5.7.
Benelux Union
9.2.4.5.7.1.
Market Estimation, 2015 - 2021
9.2.4.5.7.2.
Market Forecast, 2022 - 2030
9.2.4.5.8.
Rest of Europe
9.2.4.5.8.1.
Market Estimation, 2015 - 2021
9.2.4.5.8.2.
Market Forecast, 2022 - 2030
9.2.5.
Others
9.2.5.1.
Definition
9.2.5.2.
Market Estimation and Penetration, 2015
- 2021
9.2.5.3.
Market Forecast, 2022 - 2030
9.2.5.4.
Compound Annual Growth Rate (CAGR)
9.2.5.5.
Regional Bifurcation
9.2.5.5.1.
France
9.2.5.5.1.1.
Market Estimation, 2015 - 2021
9.2.5.5.1.2.
Market Forecast, 2022 - 2030
9.2.5.5.2.
The UK
9.2.5.5.2.1.
Market Estimation, 2015 - 2021
9.2.5.5.2.2.
Market Forecast, 2022 - 2030
9.2.5.5.3.
Spain
9.2.5.5.3.1.
Market Estimation, 2015 - 2021
9.2.5.5.3.2.
Market Forecast, 2022 - 2030
9.2.5.5.4.
Germany
9.2.5.5.4.1.
Market Estimation, 2015 - 2021
9.2.5.5.4.2.
Market Forecast, 2022 - 2030
9.2.5.5.5.
Italy
9.2.5.5.5.1.
Market Estimation, 2015 - 2021
9.2.5.5.5.2.
Market Forecast, 2022 - 2030
9.2.5.5.6.
Nordic Countries
9.2.5.5.6.1.
Market Estimation, 2015 - 2021
9.2.5.5.6.2.
Market Forecast, 2022 - 2030
9.2.5.5.7.
Benelux Union
9.2.5.5.7.1.
Market Estimation, 2015 - 2021
9.2.5.5.7.2.
Market Forecast, 2022 - 2030
9.2.5.5.8.
Rest of Europe
9.2.5.5.8.1.
Market Estimation, 2015 - 2021
9.2.5.5.8.2.
Market Forecast, 2022 - 2030
9.3.
Key Segment for Channeling Investments
9.3.1.
By Medical Negligence Type
10. Europe Clinical Negligence Market Analysis and Forecasts, 2022
- 2030
10.1.
Overview
10.2.
Europe Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Application
10.2.1.
Pregnancy and Birth Injury Claims
10.2.1.1.
Definition
10.2.1.2.
Market Estimation and Penetration, 2015
- 2021
10.2.1.3.
Market Forecast, 2022 - 2030
10.2.1.4.
Compound Annual Growth Rate (CAGR)
10.2.1.5.
Regional Bifurcation
10.2.1.5.1.
France
10.2.1.5.1.1.
Market Estimation, 2015 - 2021
10.2.1.5.1.2.
Market Forecast, 2022 - 2030
10.2.1.5.2.
The UK
10.2.1.5.2.1.
Market Estimation, 2015 - 2021
10.2.1.5.2.2.
Market Forecast, 2022 - 2030
10.2.1.5.3.
Spain
10.2.1.5.3.1.
Market Estimation, 2015 - 2021
10.2.1.5.3.2.
Market Forecast, 2022 - 2030
10.2.1.5.4.
Germany
10.2.1.5.4.1.
Market Estimation, 2015 - 2021
10.2.1.5.4.2.
Market Forecast, 2022 - 2030
10.2.1.5.5.
Italy
10.2.1.5.5.1.
Market Estimation, 2015 - 2021
10.2.1.5.5.2.
Market Forecast, 2022 - 2030
10.2.1.5.6.
Nordic Countries
10.2.1.5.6.1.
Market Estimation, 2015 - 2021
10.2.1.5.6.2.
Market Forecast, 2022 - 2030
10.2.1.5.7.
Benelux Union
10.2.1.5.7.1.
Market Estimation, 2015 - 2021
10.2.1.5.7.2.
Market Forecast, 2022 - 2030
10.2.1.5.8.
Rest of Europe
10.2.1.5.8.1.
Market Estimation, 2015 - 2021
10.2.1.5.8.2.
Market Forecast, 2022 - 2030
10.2.2.
Cancer Diagnosis Claims
10.2.2.1.
Definition
10.2.2.2.
Market Estimation and Penetration, 2015
- 2021
10.2.2.3.
Market Forecast, 2022 - 2030
10.2.2.4.
Compound Annual Growth Rate (CAGR)
10.2.2.5.
Regional Bifurcation
10.2.2.5.1.
France
10.2.2.5.1.1.
Market Estimation, 2015 - 2021
10.2.2.5.1.2.
Market Forecast, 2022 - 2030
10.2.2.5.2.
The UK
10.2.2.5.2.1.
Market Estimation, 2015 - 2021
10.2.2.5.2.2.
Market Forecast, 2022 - 2030
10.2.2.5.3.
Spain
10.2.2.5.3.1.
Market Estimation, 2015 - 2021
10.2.2.5.3.2.
Market Forecast, 2022 - 2030
10.2.2.5.4.
Germany
10.2.2.5.4.1.
Market Estimation, 2015 - 2021
10.2.2.5.4.2.
Market Forecast, 2022 - 2030
10.2.2.5.5.
Italy
10.2.2.5.5.1.
Market Estimation, 2015 - 2021
10.2.2.5.5.2.
Market Forecast, 2022 - 2030
10.2.2.5.6.
Nordic Countries
10.2.2.5.6.1.
Market Estimation, 2015 - 2021
10.2.2.5.6.2.
Market Forecast, 2022 - 2030
10.2.2.5.7.
Benelux Union
10.2.2.5.7.1.
Market Estimation, 2015 - 2021
10.2.2.5.7.2.
Market Forecast, 2022 - 2030
10.2.2.5.8.
Rest of Europe
10.2.2.5.8.1.
Market Estimation, 2015 - 2021
10.2.2.5.8.2.
Market Forecast, 2022 - 2030
10.2.3.
Cardiology Claims
10.2.3.1.
Definition
10.2.3.2.
Market Estimation and Penetration, 2015
- 2021
10.2.3.3.
Market Forecast, 2022 - 2030
10.2.3.4.
Compound Annual Growth Rate (CAGR)
10.2.3.5.
Regional Bifurcation
10.2.3.5.1.
France
10.2.3.5.1.1.
Market Estimation, 2015 - 2021
10.2.3.5.1.2.
Market Forecast, 2022 - 2030
10.2.3.5.2.
The UK
10.2.3.5.2.1.
Market Estimation, 2015 - 2021
10.2.3.5.2.2.
Market Forecast, 2022 - 2030
10.2.3.5.3.
Spain
10.2.3.5.3.1.
Market Estimation, 2015 - 2021
10.2.3.5.3.2.
Market Forecast, 2022 - 2030
10.2.3.5.4.
Germany
10.2.3.5.4.1.
Market Estimation, 2015 - 2021
10.2.3.5.4.2.
Market Forecast, 2022 - 2030
10.2.3.5.5.
Italy
10.2.3.5.5.1.
Market Estimation, 2015 - 2021
10.2.3.5.5.2.
Market Forecast, 2022 - 2030
10.2.3.5.6.
Nordic Countries
10.2.3.5.6.1.
Market Estimation, 2015 - 2021
10.2.3.5.6.2.
Market Forecast, 2022 - 2030
10.2.3.5.7.
Benelux Union
10.2.3.5.7.1.
Market Estimation, 2015 - 2021
10.2.3.5.7.2.
Market Forecast, 2022 - 2030
10.2.3.5.8.
Rest of Europe
10.2.3.5.8.1.
Market Estimation, 2015 - 2021
10.2.3.5.8.2.
Market Forecast, 2022 - 2030
10.2.4.
Dental Claims
10.2.4.1.
Definition
10.2.4.2.
Market Estimation and Penetration, 2015
- 2021
10.2.4.3.
Market Forecast, 2022 - 2030
10.2.4.4.
Compound Annual Growth Rate (CAGR)
10.2.4.5.
Regional Bifurcation
10.2.4.5.1.
France
10.2.4.5.1.1.
Market Estimation, 2015 - 2021
10.2.4.5.1.2.
Market Forecast, 2022 - 2030
10.2.4.5.2.
The UK
10.2.4.5.2.1.
Market Estimation, 2015 - 2021
10.2.4.5.2.2.
Market Forecast, 2022 - 2030
10.2.4.5.3.
Spain
10.2.4.5.3.1.
Market Estimation, 2015 - 2021
10.2.4.5.3.2.
Market Forecast, 2022 - 2030
10.2.4.5.4.
Germany
10.2.4.5.4.1.
Market Estimation, 2015 - 2021
10.2.4.5.4.2.
Market Forecast, 2022 - 2030
10.2.4.5.5.
Italy
10.2.4.5.5.1.
Market Estimation, 2015 - 2021
10.2.4.5.5.2.
Market Forecast, 2022 - 2030
10.2.4.5.6.
Nordic Countries
10.2.4.5.6.1.
Market Estimation, 2015 - 2021
10.2.4.5.6.2.
Market Forecast, 2022 - 2030
10.2.4.5.7.
Benelux Union
10.2.4.5.7.1.
Market Estimation, 2015 - 2021
10.2.4.5.7.2.
Market Forecast, 2022 - 2030
10.2.4.5.8.
Rest of Europe
10.2.4.5.8.1.
Market Estimation, 2015 - 2021
10.2.4.5.8.2.
Market Forecast, 2022 - 2030
10.2.5.
Orthopedic Claim
10.2.5.1.
Definition
10.2.5.2.
Market Estimation and Penetration, 2015
- 2021
10.2.5.3.
Market Forecast, 2022 - 2030
10.2.5.4.
Compound Annual Growth Rate (CAGR)
10.2.5.5.
Regional Bifurcation
10.2.5.5.1.
France
10.2.5.5.1.1.
Market Estimation, 2015 - 2021
10.2.5.5.1.2.
Market Forecast, 2022 - 2030
10.2.5.5.2.
The UK
10.2.5.5.2.1.
Market Estimation, 2015 - 2021
10.2.5.5.2.2.
Market Forecast, 2022 - 2030
10.2.5.5.3.
Spain
10.2.5.5.3.1.
Market Estimation, 2015 - 2021
10.2.5.5.3.2.
Market Forecast, 2022 - 2030
10.2.5.5.4.
Germany
10.2.5.5.4.1.
Market Estimation, 2015 - 2021
10.2.5.5.4.2.
Market Forecast, 2022 - 2030
10.2.5.5.5.
Italy
10.2.5.5.5.1.
Market Estimation, 2015 - 2021
10.2.5.5.5.2.
Market Forecast, 2022 - 2030
10.2.5.5.6.
Nordic Countries
10.2.5.5.6.1.
Market Estimation, 2015 - 2021
10.2.5.5.6.2.
Market Forecast, 2022 - 2030
10.2.5.5.7.
Benelux Union
10.2.5.5.7.1.
Market Estimation, 2015 - 2021
10.2.5.5.7.2.
Market Forecast, 2022 - 2030
10.2.5.5.8.
Rest of Europe
10.2.5.5.8.1.
Market Estimation, 2015 - 2021
10.2.5.5.8.2.
Market Forecast, 2022 - 2030
10.2.6.
ENT Claims
10.2.6.1.
Definition
10.2.6.2.
Market Estimation and Penetration, 2015
- 2021
10.2.6.3.
Market Forecast, 2022 - 2030
10.2.6.4.
Compound Annual Growth Rate (CAGR)
10.2.6.5.
Regional Bifurcation
10.2.6.5.1.
France
10.2.6.5.1.1.
Market Estimation, 2015 - 2021
10.2.6.5.1.2.
Market Forecast, 2022 - 2030
10.2.6.5.2.
The UK
10.2.6.5.2.1.
Market Estimation, 2015 - 2021
10.2.6.5.2.2.
Market Forecast, 2022 - 2030
10.2.6.5.3.
Spain
10.2.6.5.3.1.
Market Estimation, 2015 - 2021
10.2.6.5.3.2.
Market Forecast, 2022 - 2030
10.2.6.5.4.
Germany
10.2.6.5.4.1.
Market Estimation, 2015 - 2021
10.2.6.5.4.2.
Market Forecast, 2022 - 2030
10.2.6.5.5.
Italy
10.2.6.5.5.1.
Market Estimation, 2015 - 2021
10.2.6.5.5.2.
Market Forecast, 2022 - 2030
10.2.6.5.6.
Nordic Countries
10.2.6.5.6.1.
Market Estimation, 2015 - 2021
10.2.6.5.6.2.
Market Forecast, 2022 - 2030
10.2.6.5.7.
Benelux Union
10.2.6.5.7.1.
Market Estimation, 2015 - 2021
10.2.6.5.7.2.
Market Forecast, 2022 - 2030
10.2.6.5.8.
Rest of Europe
10.2.6.5.8.1.
Market Estimation, 2015 - 2021
10.2.6.5.8.2.
Market Forecast, 2022 - 2030
10.2.7.
Medication Errors and Pharmacy Claims
10.2.7.1.
Definition
10.2.7.2.
Market Estimation and Penetration, 2015
- 2021
10.2.7.3.
Market Forecast, 2022 - 2030
10.2.7.4.
Compound Annual Growth Rate (CAGR)
10.2.7.5.
Regional Bifurcation
10.2.7.5.1.
France
10.2.7.5.1.1.
Market Estimation, 2015 - 2021
10.2.7.5.1.2.
Market Forecast, 2022 - 2030
10.2.7.5.2.
The UK
10.2.7.5.2.1.
Market Estimation, 2015 - 2021
10.2.7.5.2.2.
Market Forecast, 2022 - 2030
10.2.7.5.3.
Spain
10.2.7.5.3.1.
Market Estimation, 2015 - 2021
10.2.7.5.3.2.
Market Forecast, 2022 - 2030
10.2.7.5.4.
Germany
10.2.7.5.4.1.
Market Estimation, 2015 - 2021
10.2.7.5.4.2.
Market Forecast, 2022 - 2030
10.2.7.5.5.
Italy
10.2.7.5.5.1.
Market Estimation, 2015 - 2021
10.2.7.5.5.2.
Market Forecast, 2022 - 2030
10.2.7.5.6.
Nordic Countries
10.2.7.5.6.1.
Market Estimation, 2015 - 2021
10.2.7.5.6.2.
Market Forecast, 2022 - 2030
10.2.7.5.7.
Benelux Union
10.2.7.5.7.1.
Market Estimation, 2015 - 2021
10.2.7.5.7.2.
Market Forecast, 2022 - 2030
10.2.7.5.8.
Rest of Europe
10.2.7.5.8.1.
Market Estimation, 2015 - 2021
10.2.7.5.8.2.
Market Forecast, 2022 - 2030
10.2.8.
Pediatric Injury Claim
10.2.8.1.
Definition
10.2.8.2.
Market Estimation and Penetration, 2015
- 2021
10.2.8.3.
Market Forecast, 2022 - 2030
10.2.8.4.
Compound Annual Growth Rate (CAGR)
10.2.8.5.
Regional Bifurcation
10.2.8.5.1.
France
10.2.8.5.1.1.
Market Estimation, 2015 - 2021
10.2.8.5.1.2.
Market Forecast, 2022 - 2030
10.2.8.5.2.
The UK
10.2.8.5.2.1.
Market Estimation, 2015 - 2021
10.2.8.5.2.2.
Market Forecast, 2022 - 2030
10.2.8.5.3.
Spain
10.2.8.5.3.1.
Market Estimation, 2015 - 2021
10.2.8.5.3.2.
Market Forecast, 2022 - 2030
10.2.8.5.4.
Germany
10.2.8.5.4.1.
Market Estimation, 2015 - 2021
10.2.8.5.4.2.
Market Forecast, 2022 - 2030
10.2.8.5.5.
Italy
10.2.8.5.5.1.
Market Estimation, 2015 - 2021
10.2.8.5.5.2.
Market Forecast, 2022 - 2030
10.2.8.5.6.
Nordic Countries
10.2.8.5.6.1.
Market Estimation, 2015 - 2021
10.2.8.5.6.2.
Market Forecast, 2022 - 2030
10.2.8.5.7.
Benelux Union
10.2.8.5.7.1.
Market Estimation, 2015 - 2021
10.2.8.5.7.2.
Market Forecast, 2022 - 2030
10.2.8.5.8.
Rest of Europe
10.2.8.5.8.1.
Market Estimation, 2015 - 2021
10.2.8.5.8.2.
Market Forecast, 2022 - 2030
10.2.9.
Personal Injury Claim
10.2.9.1.
Definition
10.2.9.2.
Market Estimation and Penetration, 2015
- 2021
10.2.9.3.
Market Forecast, 2022 - 2030
10.2.9.4.
Compound Annual Growth Rate (CAGR)
10.2.9.5.
Regional Bifurcation
10.2.9.5.1.
France
10.2.9.5.1.1.
Market Estimation, 2015 - 2021
10.2.9.5.1.2.
Market Forecast, 2022 - 2030
10.2.9.5.2.
The UK
10.2.9.5.2.1.
Market Estimation, 2015 - 2021
10.2.9.5.2.2.
Market Forecast, 2022 - 2030
10.2.9.5.3.
Spain
10.2.9.5.3.1.
Market Estimation, 2015 - 2021
10.2.9.5.3.2.
Market Forecast, 2022 - 2030
10.2.9.5.4.
Germany
10.2.9.5.4.1.
Market Estimation, 2015 - 2021
10.2.9.5.4.2.
Market Forecast, 2022 - 2030
10.2.9.5.5.
Italy
10.2.9.5.5.1.
Market Estimation, 2015 - 2021
10.2.9.5.5.2.
Market Forecast, 2022 - 2030
10.2.9.5.6.
Nordic Countries
10.2.9.5.6.1.
Market Estimation, 2015 - 2021
10.2.9.5.6.2.
Market Forecast, 2022 - 2030
10.2.9.5.7.
Benelux Union
10.2.9.5.7.1.
Market Estimation, 2015 - 2021
10.2.9.5.7.2.
Market Forecast, 2022 - 2030
10.2.9.5.8.
Rest of Europe
10.2.9.5.8.1.
Market Estimation, 2015 - 2021
10.2.9.5.8.2.
Market Forecast, 2022 - 2030
10.2.10.
Cerebral Palsy Claim
10.2.10.1.
Definition
10.2.10.2.
Market Estimation and Penetration, 2015
- 2021
10.2.10.3.
Market Forecast, 2022 - 2030
10.2.10.4.
Compound Annual Growth Rate (CAGR)
10.2.10.5.
Regional Bifurcation
10.2.10.5.1.
France
10.2.10.5.1.1.
Market Estimation, 2015 - 2021
10.2.10.5.1.2.
Market Forecast, 2022 - 2030
10.2.10.5.2.
The UK
10.2.10.5.2.1.
Market Estimation, 2015 - 2021
10.2.10.5.2.2.
Market Forecast, 2022 - 2030
10.2.10.5.3.
Spain
10.2.10.5.3.1.
Market Estimation, 2015 - 2021
10.2.10.5.3.2.
Market Forecast, 2022 - 2030
10.2.10.5.4.
Germany
10.2.10.5.4.1.
Market Estimation, 2015 - 2021
10.2.10.5.4.2.
Market Forecast, 2022 - 2030
10.2.10.5.5.
Italy
10.2.10.5.5.1.
Market Estimation, 2015 - 2021
10.2.10.5.5.2.
Market Forecast, 2022 - 2030
10.2.10.5.6.
Nordic Countries
10.2.10.5.6.1.
Market Estimation, 2015 - 2021
10.2.10.5.6.2.
Market Forecast, 2022 - 2030
10.2.10.5.7.
Benelux Union
10.2.10.5.7.1.
Market Estimation, 2015 - 2021
10.2.10.5.7.2.
Market Forecast, 2022 - 2030
10.2.10.5.8.
Rest of Europe
10.2.10.5.8.1.
Market Estimation, 2015 - 2021
10.2.10.5.8.2.
Market Forecast, 2022 - 2030
10.2.11.
Others
10.2.11.1.
Definition
10.2.11.2.
Market Estimation and Penetration, 2015
- 2021
10.2.11.3.
Market Forecast, 2022 - 2030
10.2.11.4.
Compound Annual Growth Rate (CAGR)
10.2.11.5.
Regional Bifurcation
10.2.11.5.1.
France
10.2.11.5.1.1.
Market Estimation, 2015 - 2021
10.2.11.5.1.2.
Market Forecast, 2022 - 2030
10.2.11.5.2.
The UK
10.2.11.5.2.1.
Market Estimation, 2015 - 2021
10.2.11.5.2.2.
Market Forecast, 2022 - 2030
10.2.11.5.3.
Spain
10.2.11.5.3.1.
Market Estimation, 2015 - 2021
10.2.11.5.3.2.
Market Forecast, 2022 - 2030
10.2.11.5.4.
Germany
10.2.11.5.4.1.
Market Estimation, 2015 - 2021
10.2.11.5.4.2.
Market Forecast, 2022 - 2030
10.2.11.5.5.
Italy
10.2.11.5.5.1.
Market Estimation, 2015 - 2021
10.2.11.5.5.2.
Market Forecast, 2022 - 2030
10.2.11.5.6.
Nordic Countries
10.2.11.5.6.1.
Market Estimation, 2015 - 2021
10.2.11.5.6.2.
Market Forecast, 2022 - 2030
10.2.11.5.7.
Benelux Union
10.2.11.5.7.1.
Market Estimation, 2015 - 2021
10.2.11.5.7.2.
Market Forecast, 2022 - 2030
10.2.11.5.8.
Rest of Europe
10.2.11.5.8.1.
Market Estimation, 2015 - 2021
10.2.11.5.8.2.
Market Forecast, 2022 - 2030
10.3.
Key Segment for Channeling Investments
10.3.1.
By Application
11. Europe Clinical Negligence Market Analysis and Forecasts, 2022
- 2030
11.1.
Overview
11.1.1.
Europe Clinical Negligence Market
Revenue (US$ Mn)
11.2.
Europe Clinical Negligence Market
Revenue (US$ Mn), By Country
11.2.1.
France
11.2.1.1.
France Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.1.1.1.
Private Practitioners and Healthcare
Facilities
11.2.1.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.1.2.
France Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.1.2.1.
Misdiagnosis and Negligence
11.2.1.2.2.
Delayed Diagnosis
11.2.1.2.3.
Incorrect Treatment
11.2.1.2.4.
Surgical Mistakes
11.2.1.2.5.
Others
11.2.1.3.
France Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Application
11.2.1.3.1.
Pregnancy and Birth Injury Claims
11.2.1.3.2.
Cancer Diagnosis Claims
11.2.1.3.3.
Cardiology Claims
11.2.1.3.4.
Dental Claims
11.2.1.3.5.
Orthopedic Claim
11.2.1.3.6.
ENT Claims
11.2.1.3.7.
Medication Errors and Pharmacy Claims
11.2.1.3.8.
Pediatric Injury Claim
11.2.1.3.9.
Personal Injury Claim
11.2.1.3.10.
Cerebral Palsy Claim
11.2.1.3.11.
Others
11.2.2.
The UK
11.2.2.1.
The UK Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.2.1.1.
Private Practitioners and Healthcare
Facilities
11.2.2.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.2.2.
The UK Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.2.2.1.
Misdiagnosis and Negligence
11.2.2.2.2.
Delayed Diagnosis
11.2.2.2.3.
Incorrect Treatment
11.2.2.2.4.
Surgical Mistakes
11.2.2.2.5.
Others
11.2.2.3.
The UK Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Application
11.2.2.3.1.
Pregnancy and Birth Injury Claims
11.2.2.3.2.
Cancer Diagnosis Claims
11.2.2.3.3.
Cardiology Claims
11.2.2.3.4.
Dental Claims
11.2.2.3.5.
Orthopedic Claim
11.2.2.3.6.
ENT Claims
11.2.2.3.7.
Medication Errors and Pharmacy Claims
11.2.2.3.8.
Pediatric Injury Claim
11.2.2.3.9.
Personal Injury Claim
11.2.2.3.10.
Cerebral Palsy Claim
11.2.2.3.11.
Others
11.2.3.
Spain
11.2.3.1.
Spain Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.3.1.1.
Private Practitioners and Healthcare Facilities
11.2.3.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.3.2.
Spain Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.3.2.1.
Misdiagnosis and Negligence
11.2.3.2.2.
Delayed Diagnosis
11.2.3.2.3.
Incorrect Treatment
11.2.3.2.4.
Surgical Mistakes
11.2.3.2.5.
Others
11.2.3.3.
Spain Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Application
11.2.3.3.1.
Pregnancy and Birth Injury Claims
11.2.3.3.2.
Cancer Diagnosis Claims
11.2.3.3.3.
Cardiology Claims
11.2.3.3.4.
Dental Claims
11.2.3.3.5.
Orthopedic Claim
11.2.3.3.6.
ENT Claims
11.2.3.3.7.
Medication Errors and Pharmacy Claims
11.2.3.3.8.
Pediatric Injury Claim
11.2.3.3.9.
Personal Injury Claim
11.2.3.3.10.
Cerebral Palsy Claim
11.2.3.3.11.
Others
11.2.4.
Germany
11.2.4.1.
Germany Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.4.1.1.
Private Practitioners and Healthcare
Facilities
11.2.4.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.4.2.
Germany Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.4.2.1.
Misdiagnosis and Negligence
11.2.4.2.2.
Delayed Diagnosis
11.2.4.2.3.
Incorrect Treatment
11.2.4.2.4.
Surgical Mistakes
11.2.4.2.5.
Others
11.2.4.3.
Germany Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Application
11.2.4.3.1.
Pregnancy and Birth Injury Claims
11.2.4.3.2.
Cancer Diagnosis Claims
11.2.4.3.3.
Cardiology Claims
11.2.4.3.4.
Dental Claims
11.2.4.3.5.
Orthopedic Claim
11.2.4.3.6.
ENT Claims
11.2.4.3.7.
Medication Errors and Pharmacy Claims
11.2.4.3.8.
Pediatric Injury Claim
11.2.4.3.9.
Personal Injury Claim
11.2.4.3.10.
Cerebral Palsy Claim
11.2.4.3.11.
Others
11.2.5.
Italy
11.2.5.1.
Italy Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.5.1.1.
Private Practitioners and Healthcare
Facilities
11.2.5.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.5.2.
Italy Clinical Negligence Market Revenue
(US$ Mn) and Forecasts, By Medical Negligence Type
11.2.5.2.1.
Misdiagnosis and Negligence
11.2.5.2.2.
Delayed Diagnosis
11.2.5.2.3.
Incorrect Treatment
11.2.5.2.4.
Surgical Mistakes
11.2.5.2.5.
Others
11.2.5.3.
Italy Clinical Negligence Market
Revenue (US$ Mn) and Forecasts, By Application
11.2.5.3.1.
Pregnancy and Birth Injury Claims
11.2.5.3.2.
Cancer Diagnosis Claims
11.2.5.3.3.
Cardiology Claims
11.2.5.3.4.
Dental Claims
11.2.5.3.5.
Orthopedic Claim
11.2.5.3.6.
ENT Claims
11.2.5.3.7.
Medication Errors and Pharmacy Claims
11.2.5.3.8.
Pediatric Injury Claim
11.2.5.3.9.
Personal Injury Claim
11.2.5.3.10.
Cerebral Palsy Claim
11.2.5.3.11.
Others
11.2.6.
Nordic Countries
11.2.6.1.
Nordic Countries Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.6.1.1.
Private Practitioners and Healthcare
Facilities
11.2.6.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.6.2.
Nordic Countries Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.6.2.1.
Misdiagnosis and Negligence
11.2.6.2.2.
Delayed Diagnosis
11.2.6.2.3.
Incorrect Treatment
11.2.6.2.4.
Surgical Mistakes
11.2.6.2.5.
Others
11.2.6.3.
Nordic Countries Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Application
11.2.6.3.1.
Pregnancy and Birth Injury Claims
11.2.6.3.2.
Cancer Diagnosis Claims
11.2.6.3.3.
Cardiology Claims
11.2.6.3.4.
Dental Claims
11.2.6.3.5.
Orthopedic Claim
11.2.6.3.6.
ENT Claims
11.2.6.3.7.
Medication Errors and Pharmacy Claims
11.2.6.3.8.
Pediatric Injury Claim
11.2.6.3.9.
Personal Injury Claim
11.2.6.3.10.
Cerebral Palsy Claim
11.2.6.3.11.
Others
11.2.6.4.
Nordic Countries Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Country
11.2.6.4.1.
Denmark
11.2.6.4.2.
Finland
11.2.6.4.3.
Iceland
11.2.6.4.4.
Sweden
11.2.6.4.5.
Norway
11.2.7.
Benelux Union
11.2.7.1.
Benelux Union Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.7.1.1.
Private Practitioners and Healthcare
Facilities
11.2.7.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.7.2.
Benelux Union Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.7.2.1.
Misdiagnosis and Negligence
11.2.7.2.2.
Delayed Diagnosis
11.2.7.2.3.
Incorrect Treatment
11.2.7.2.4.
Surgical Mistakes
11.2.7.2.5.
Others
11.2.7.3.
Benelux Union Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Application
11.2.7.3.1.
Pregnancy and Birth Injury Claims
11.2.7.3.2.
Cancer Diagnosis Claims
11.2.7.3.3.
Cardiology Claims
11.2.7.3.4.
Dental Claims
11.2.7.3.5.
Orthopedic Claim
11.2.7.3.6.
ENT Claims
11.2.7.3.7.
Medication Errors and Pharmacy Claims
11.2.7.3.8.
Pediatric Injury Claim
11.2.7.3.9.
Personal Injury Claim
11.2.7.3.10.
Cerebral Palsy Claim
11.2.7.3.11.
Others
11.2.7.4.
Benelux Union Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Country
11.2.7.4.1.
Belgium
11.2.7.4.2.
The Netherlands
11.2.7.4.3.
Luxembourg
11.2.8.
Rest of Europe
11.2.8.1.
Rest of Europe Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Treatment Provider
11.2.8.1.1.
Private Practitioners and Healthcare
Facilities
11.2.8.1.2.
National Health Service
(NHS)Practitioners and Healthcare Facilities
11.2.8.2.
Rest of Europe Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Medical Negligence Type
11.2.8.2.1.
Misdiagnosis and Negligence
11.2.8.2.2.
Delayed Diagnosis
11.2.8.2.3.
Incorrect Treatment
11.2.8.2.4.
Surgical Mistakes
11.2.8.2.5.
Others
11.2.8.3.
Rest of Europe Clinical Negligence
Market Revenue (US$ Mn) and Forecasts, By Application
11.2.8.3.1.
Pregnancy and Birth Injury Claims
11.2.8.3.2.
Cancer Diagnosis Claims
11.2.8.3.3.
Cardiology Claims
11.2.8.3.4.
Dental Claims
11.2.8.3.5.
Orthopedic Claim
11.2.8.3.6.
ENT Claims
11.2.8.3.7.
Medication Errors and Pharmacy Claims
11.2.8.3.8.
Pediatric Injury Claim
11.2.8.3.9.
Personal Injury Claim
11.2.8.3.10.
Cerebral Palsy Claim
11.2.8.3.11.
Others
11.3.
Key Segment for Channeling Investments
11.3.1.
By Country
12. Competitive Benchmarking
12.1.
Brand Benchmarking
12.2. Market
Share Analysis, 2021
12.3.
Europe Presence and Growth Strategies
12.3.1.
Mergers and Acquisitions
12.3.2.
Product Launches
12.3.3.
Investments Trends
12.3.4.
R&D Initiatives
13. Player Profiles
13.1.
Anthony Gold Solicitors LLP
13.1.1.
Company Details
13.1.2.
Company Overview
13.1.3.
Product Offerings
13.1.4.
Key Developments
13.1.5.
Financial Analysis
13.1.6.
SWOT Analysis
13.1.7.
Business Strategies
13.2.
Bolt Burdon Kemp
13.2.1.
Company Details
13.2.2.
Company Overview
13.2.3.
Product Offerings
13.2.4.
Key Developments
13.2.5.
Financial Analysis
13.2.6.
SWOT Analysis
13.2.7.
Business Strategies
13.3.
Clarke Willmott LLP.
13.3.1.
Company Details
13.3.2.
Company Overview
13.3.3.
Product Offerings
13.3.4.
Key Developments
13.3.5.
Financial Analysis
13.3.6.
SWOT Analysis
13.3.7.
Business Strategies
13.4.
Clyde & Co LLP
13.4.1.
Company Details
13.4.2.
Company Overview
13.4.3.
Product Offerings
13.4.4.
Key Developments
13.4.5.
Financial Analysis
13.4.6.
SWOT Analysis
13.4.7.
Business Strategies
13.5.
Fieldfisher
13.5.1.
Company Details
13.5.2.
Company Overview
13.5.3.
Product Offerings
13.5.4.
Key Developments
13.5.5.
Financial Analysis
13.5.6.
SWOT Analysis
13.5.7.
Business Strategies
13.6.
Fletchers Solicitors
13.6.1.
Company Details
13.6.2.
Company Overview
13.6.3.
Product Offerings
13.6.4.
Key Developments
13.6.5.
Financial Analysis
13.6.6.
SWOT Analysis
13.6.7.
Business Strategies
13.7.
Forbes Solicitors LLP
13.7.1.
Company Details
13.7.2.
Company Overview
13.7.3.
Product Offerings
13.7.4.
Key Developments
13.7.5.
Financial Analysis
13.7.6.
SWOT Analysis
13.7.7.
Business Strategies
13.8.
Hodge Jones & Allen Solicitors
Limited
13.8.1.
Company Details
13.8.2.
Company Overview
13.8.3.
Product Offerings
13.8.4.
Key Developments
13.8.5.
Financial Analysis
13.8.6.
SWOT Analysis
13.8.7.
Business Strategies
13.9.
Irwin Mitchell LLP
13.9.1.
Company Details
13.9.2.
Company Overview
13.9.3.
Product Offerings
13.9.4.
Key Developments
13.9.5.
Financial Analysis
13.9.6.
SWOT Analysis
13.9.7.
Business Strategies
13.10.
Kingsley Napley LLP
13.10.1.
Company Details
13.10.2.
Company Overview
13.10.3.
Product Offerings
13.10.4.
Key Developments
13.10.5.
Financial Analysis
13.10.6.
SWOT Analysis
13.10.7.
Business Strategies
13.11.
Leigh Day
13.11.1.
Company Details
13.11.2.
Company Overview
13.11.3.
Product Offerings
13.11.4.
Key Developments
13.11.5.
Financial Analysis
13.11.6.
SWOT Analysis
13.11.7.
Business Strategies
13.12.
Lime Solicitors
13.12.1.
Company Details
13.12.2.
Company Overview
13.12.3.
Product Offerings
13.12.4.
Key Developments
13.12.5.
Financial Analysis
13.12.6.
SWOT Analysis
13.12.7.
Business Strategies
13.13.
Longden Walker & Renney Solicitors
13.13.1.
Company Details
13.13.2.
Company Overview
13.13.3.
Product Offerings
13.13.4.
Key Developments
13.13.5.
Financial Analysis
13.13.6.
SWOT Analysis
13.13.7.
Business Strategies
13.14.
Stewarts Law LLP
13.14.1.
Company Details
13.14.2.
Company Overview
13.14.3.
Product Offerings
13.14.4.
Key Developments
13.14.5.
Financial Analysis
13.14.6.
SWOT Analysis
13.14.7.
Business Strategies
13.15.
Thompsons Solicitors LLP
13.15.1.
Company Details
13.15.2.
Company Overview
13.15.3.
Product Offerings
13.15.4.
Key Developments
13.15.5.
Financial Analysis
13.15.6.
SWOT Analysis
13.15.7.
Business Strategies
13.16.
Other Market Participants
14. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.